{"title":"Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.","authors":"Elin Holmén, Anna Warnqvist, Martin Kåberg","doi":"10.1186/s13011-023-00533-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Opioid overdoses are a growing concern, particularly among people who inject drugs. Sweden, with a comparatively high proportion of drug-related mortality, introduced its first Take-Home Naloxone (THN) program in 2018, at the Stockholm needle and syringe program (NSP). In this study we compare THN participant characteristics regarding refills and overdose reversals as well as investigate predictors associated with number of reversals. We also investigate interventions performed in overdose situations and endpoints for naloxone doses.</p><p><strong>Methods: </strong>This was a prospective open inclusion cohort study conducted between January 24<sup>th</sup> 2018 and March 31<sup>st</sup> 2022 at the Stockholm NSP. Participants received THN, free of charge, after a training session and provided data regarding drug use and overdose experiences. During refill visits, participants reported if the naloxone was used for overdose reversal and, if so, responded to a ten-item questionnaire which included stating whether the naloxone recipient was the participant themselves or somebody else. Questionnaire data was combined with NSP database demographic data. Zero-inflated Poisson regression was applied to analyse predictors for number of reported overdose reversals.</p><p><strong>Results: </strong>Among study participants (n = 1,295), 66.5% stated opioids as their primary drug, and 61.4% and 81.0% had previous experience of a personal or witnessed overdose, respectively. Overall, 44.0% of participants reported a total of 1,625 overdose reversals and the victim was known to have survived in 95.6% of cases. Stimulant use (aIRR 1.26; 95% CI 1.01, 1.58), benzodiazepine use (aIRR 1.75; 95% CI 1.1, 2.78) and homelessness (aIRR 1.35; 95% CI 1.06, 1.73) were predictors associated with an increased number of reported overdose reversals. Mortality was higher among those who reported at least one overdose reversal (HR 3.4; 95% CI 2.2, 5.2).</p><p><strong>Conclusions: </strong>An NSP's existent framework can be utilised to effectively implement a THN program, provide basic training and reach numerous high-risk individuals. During the four-year study, THN participants reversed a sizeable number of potentially fatal overdoses, of which many were reported by participants whose primary drug was not opioids. Naloxone refill rate was high, indicating that participants were motivated to maintain a supply of naloxone in case of future overdose events.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"18 1","pages":"24"},"PeriodicalIF":3.0000,"publicationDate":"2023-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121425/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Substance Abuse Treatment, Prevention, and Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13011-023-00533-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Opioid overdoses are a growing concern, particularly among people who inject drugs. Sweden, with a comparatively high proportion of drug-related mortality, introduced its first Take-Home Naloxone (THN) program in 2018, at the Stockholm needle and syringe program (NSP). In this study we compare THN participant characteristics regarding refills and overdose reversals as well as investigate predictors associated with number of reversals. We also investigate interventions performed in overdose situations and endpoints for naloxone doses.
Methods: This was a prospective open inclusion cohort study conducted between January 24th 2018 and March 31st 2022 at the Stockholm NSP. Participants received THN, free of charge, after a training session and provided data regarding drug use and overdose experiences. During refill visits, participants reported if the naloxone was used for overdose reversal and, if so, responded to a ten-item questionnaire which included stating whether the naloxone recipient was the participant themselves or somebody else. Questionnaire data was combined with NSP database demographic data. Zero-inflated Poisson regression was applied to analyse predictors for number of reported overdose reversals.
Results: Among study participants (n = 1,295), 66.5% stated opioids as their primary drug, and 61.4% and 81.0% had previous experience of a personal or witnessed overdose, respectively. Overall, 44.0% of participants reported a total of 1,625 overdose reversals and the victim was known to have survived in 95.6% of cases. Stimulant use (aIRR 1.26; 95% CI 1.01, 1.58), benzodiazepine use (aIRR 1.75; 95% CI 1.1, 2.78) and homelessness (aIRR 1.35; 95% CI 1.06, 1.73) were predictors associated with an increased number of reported overdose reversals. Mortality was higher among those who reported at least one overdose reversal (HR 3.4; 95% CI 2.2, 5.2).
Conclusions: An NSP's existent framework can be utilised to effectively implement a THN program, provide basic training and reach numerous high-risk individuals. During the four-year study, THN participants reversed a sizeable number of potentially fatal overdoses, of which many were reported by participants whose primary drug was not opioids. Naloxone refill rate was high, indicating that participants were motivated to maintain a supply of naloxone in case of future overdose events.
背景:阿片类药物过量是一个日益受到关注的问题,特别是在注射毒品的人群中。瑞典与毒品相关的死亡率相对较高,于2018年在斯德哥尔摩针头和注射器计划(NSP)推出了首个纳洛酮带回家(THN)计划。在这项研究中,我们比较了THN参与者关于再填充和过量逆转的特征,并调查了与逆转次数相关的预测因素。我们还调查了纳洛酮剂量过量情况下的干预措施和终点。方法:这是一项前瞻性开放纳入队列研究,于2018年1月24日至2022年3月31日在斯德哥尔摩NSP进行。参与者在培训课程后免费获得THN,并提供有关药物使用和过量经验的数据。在补充访问期间,参与者报告纳洛酮是否用于过量逆转,如果是,则回答一份十项问卷,其中包括纳洛酮接受者是参与者自己还是其他人。问卷调查数据与NSP数据库人口统计数据相结合。零膨胀泊松回归用于分析报告的过量逆转数量的预测因子。结果:在研究参与者(n = 1,295)中,66.5%的人表示阿片类药物是他们的主要药物,61.4%和81.0%的人分别有过个人或目击过量用药的经历。总体而言,44.0%的参与者报告了1,625例过量逆转,受害者在95.6%的病例中已知存活。兴奋剂使用(aIRR 1.26;95% CI 1.01, 1.58),苯二氮卓类药物使用(aIRR 1.75;95% CI 1.1, 2.78)和无家可归(aIRR 1.35;95% CI 1.06, 1.73)是与报告的过量逆转数量增加相关的预测因子。报告至少一次药物过量逆转的患者死亡率更高(HR 3.4;95% ci 2.2, 5.2)。结论:NSP现有的框架可以有效地实施THN计划,提供基本培训并覆盖众多高危人群。在为期四年的研究中,THN参与者扭转了相当数量可能致命的过量用药,其中许多参与者报告的主要药物不是阿片类药物。纳洛酮补充率很高,表明参与者有动力维持纳洛酮的供应,以防未来过量事件。
期刊介绍:
Substance Abuse Treatment, Prevention, and Policy is an open access, peer-reviewed journal that encompasses research concerning substance abuse, with a focus on policy issues. The journal aims to provide an environment for the exchange of ideas, new research, consensus papers, and critical reviews, to bridge the established fields that share a mutual goal of reducing the harms from substance use. These fields include: legislation pertaining to substance use; correctional supervision of people with substance use disorder; medical treatment and screening; mental health services; research; and evaluation of substance use disorder programs.